Page last updated: 2024-09-02

ci 988 and zimeldine

ci 988 has been researched along with zimeldine in 1 studies

Compound Research Comparison

Studies
(ci 988)
Trials
(ci 988)
Recent Studies (post-2010)
(ci 988)
Studies
(zimeldine)
Trials
(zimeldine)
Recent Studies (post-2010) (zimeldine)
1478144909917

Protein Interaction Comparison

ProteinTaxonomyci 988 (IC50)zimeldine (IC50)
DRattus norvegicus (Norway rat)4.5
D(3) dopamine receptorRattus norvegicus (Norway rat)4.5
D(1B) dopamine receptorRattus norvegicus (Norway rat)4.5
D(4) dopamine receptorRattus norvegicus (Norway rat)4.5
Sodium-dependent serotonin transporterRattus norvegicus (Norway rat)4.5
D(2) dopamine receptorRattus norvegicus (Norway rat)4.5
TransporterRattus norvegicus (Norway rat)4.5

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bickerdike, MJ; Dourish, CT; Fletcher, A; Marsden, CA1

Other Studies

1 other study(ies) available for ci 988 and zimeldine

ArticleYear
The influence of 5-hydroxytryptamine re-uptake blockade on CCK receptor antagonist effects in the rat elevated zero-maze.
    European journal of pharmacology, 1994, Dec-27, Volume: 271, Issue:2-3

    Topics: Animals; Anti-Anxiety Agents; Benzodiazepinones; Devazepide; Diazepam; Indoles; Male; Maze Learning; Meglumine; Niacinamide; Phenylurea Compounds; Piperazines; Piperidines; Rats; Receptors, Cholecystokinin; Selective Serotonin Reuptake Inhibitors; Zimeldine

1994